Clinical Trial Update: Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant [Phase 2]

View source ↗

Summary

This clinical trial update reports that the Phase 2 study of MT-401 in patients with acute myeloid leukemia following stem cell transplantation has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• MT-401

Snippet

Sponsor: Marker Therapeutics, Inc. | Conditions: Acute Myeloid Leukemia, Stem Cell Transplantation | Phase 2 | Status: TERMINATED